- Home
- HBIO vs INMB Comparison
HBIO vs INMB Comparison
Compare HBIO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBIO
- INMB
- Stock Information
- Founded
- HBIO 1901
- INMB 2015
- Country
- HBIO United States
- INMB United States
- Employees
- HBIO N/A
- INMB N/A
- Industry
- HBIO Biotechnology: Laboratory Analytical Instruments
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- HBIO Industrials
- INMB Health Care
- Exchange
- HBIO Nasdaq
- INMB Nasdaq
- Market Cap
- HBIO 93.8M
- INMB 103.1M
- IPO Year
- HBIO 2000
- INMB 2019
- Fundamental
- Price
- HBIO $1.93
- INMB $6.45
- Analyst Decision
- HBIO
- INMB Strong Buy
- Analyst Count
- HBIO 0
- INMB 2
- Target Price
- HBIO N/A
- INMB $21.00
- AVG Volume (30 Days)
- HBIO 248.4K
- INMB 377.7K
- Earning Date
- HBIO 03-06-2025
- INMB 10-31-2024
- Dividend Yield
- HBIO N/A
- INMB N/A
- EPS Growth
- HBIO N/A
- INMB N/A
- EPS
- HBIO N/A
- INMB N/A
- Revenue
- HBIO $97,732,000.00
- INMB $42,000.00
- Revenue This Year
- HBIO N/A
- INMB N/A
- Revenue Next Year
- HBIO $4.32
- INMB N/A
- P/E Ratio
- HBIO N/A
- INMB N/A
- Revenue Growth
- HBIO N/A
- INMB N/A
- 52 Week Low
- HBIO $1.81
- INMB $4.32
- 52 Week High
- HBIO $4.93
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- HBIO 40.61
- INMB 63.48
- Support Level
- HBIO $1.81
- INMB $5.82
- Resistance Level
- HBIO $2.07
- INMB $6.83
- Average True Range (ATR)
- HBIO 0.13
- INMB 0.55
- MACD
- HBIO -0.01
- INMB 0.18
- Stochastic Oscillator
- HBIO 25.53
- INMB 83.61
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.